HPX and glioblastoma: The serum levels of hemopexin in SVZ+ GBM patients (1.72 mg/ml) were found to be marginally higher than the SVZ− GBM patients (n = 1.25 mg/ml) and have been represented in graphical form in Fig. 4a.